Acid-Resistant Capsule Technology This changes everything
Promising OS and PFS data have been shown, especially in non-squamous taxane-nave NSCLC (n=42), with a median PFS of 6.4 months (95% CI, 4.5 to 10.5) and median OS of 16.3 months (95% CI, 11.5 to NR), compared to 3.5 months (95% CI, 2.7 to 5.3) and 11.2 months (95% CI, 8.3 to 13.7), respectively, in all NSCLC subtypes [87]
Todays consumers are asking sharper questions, not just about whats in their products, but how those ingredients actually work
Cell 58 , 923931 (1989)
[BLOOD GLUTATHIONE IN CARDIOPATHIES] [PMID: 14209429] Laboratory literature summary: [BLOOD GLUTATHIONE IN CARDIOPATHIES]
Am J Geriatr Pharmacother